Immune Response in Patients with RCC

October 25, 2013
Jeffrey A. Sosman, MD

Special Reports, Genitourinary Cancers, Volume 1, Issue 1

Jeffrey A. Sosman, MD, professor of medicine, director, Melanoma and Tumor Immunotherapy Program, Vanderbilt University School of Medicine, Vanderbilt-Ingram Cancer Center, discusses immune response in renal cell carcinoma.

Jeffrey A. Sosman, MD, professor of medicine, director, Melanoma and Tumor Immunotherapy Program, Vanderbilt University School of Medicine, Vanderbilt-Ingram Cancer Center, discusses immune response in renal cell carcinoma.

The treatment of advanced renal cell carcinoma (RCC) remains a major challenge for clinicians.Read more > >